13G Filing: Visium Asset Management and Sage Therapeutics, Inc. (SAGE)

Page 4 of 11

Page 4 of 11 SEC Filing


CUSIP No. 78667J108 Page
4
of 11 Pages
  1

NAMES OF
REPORTING PERSONS

I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (Entities Only)

Jacob Gottlieb

  2

CHECK THE APPROPRIATE BOX IF A MEMBER
OF A GROUP*

(a)  ¨        (b)  ¨

  3

SEC USE ONLY

  4

CITIZENSHIP OR PLACE OF
ORGANIZATION

United States

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

5

SOLE VOTING POWER

None

6

SHARED VOTING POWER

1,893,009 (See Item 4)

7

SOLE DISPOSITIVE POWER

None

8

SHARED DISPOSITIVE POWER

1,893,009 (See Item 4)

  9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

1,893,009 (See Item 4)

10

CHECK BOX IF THE AGGREGATE AMOUNT IN
ROW (9) EXCLUDES CERTAIN SHARES*

¨

Not Applicable

11

PERCENT OF CLASS REPRESENTED BY AMOUNT
IN ROW (9)

5.9%

12

TYPE OF REPORTING PERSON*

HC, IN

Page 4 of 11 Pages

Follow Sage Therapeutics Inc. (NASDAQ:SAGE)

Page 4 of 11